What does Amylyx Pharmaceuticals, Inc. do?
Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. It provides Avexitide, an investigational, first-in-class glucagon-like peptide-1, or GLP-1 receptor…
What is Amylyx Pharmaceuticals, Inc.'s P/E and P/B ratio?
Amylyx Pharmaceuticals, Inc. has a P/E ratio of -20.3 and a P/B ratio of 14.99.
What is Amylyx Pharmaceuticals, Inc.'s debt-to-equity ratio?
Amylyx Pharmaceuticals, Inc. has a debt-to-equity ratio of 0.02.
How much does Amylyx Pharmaceuticals, Inc. owe compared with what it owns?
Amylyx Pharmaceuticals, Inc. owes $0.10 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Amylyx Pharmaceuticals, Inc.'s Positivity rank?
Amylyx Pharmaceuticals, Inc. is ranked #5,964 of 6,774 companies globally and #3,354 of 4,000 in United States on PositoAI, with a Positivity Score of 13,275.
Does Amylyx Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Amylyx Pharmaceuticals, Inc..
Where can I read the latest news about Amylyx Pharmaceuticals, Inc.?
Recent headlines about Amylyx Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Amylyx Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Amylyx Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.